Evidence map›Paper›PMID 30658617›Full record

ArticleBMC cancer2019

Obesity impacts the regulation of miR-10b and its targets in primary breast tumors.

Ari Meerson, Yaniv Eliraz, Hila Yehuda, Bridget Knight, Malcolm Crundwell, Douglas Ferguson, Benjamin P Lee, Lorna W Harries

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Significance of metastamiR-10b in breast cancer therapeutics.Journal of the Egyptian National Cancer Institute · 2022
    Review
  10. Review
  11. MicroRNA‑378d inhibitsMolecular medicine reports · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Molecular Links between Central Obesity and Breast Cancer.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ari MeersonMIGAL - Galilee Research Institute, PO Box 831, 11016, Kiryat Shmona, Israel.
Yaniv ElirazMIGAL - Galilee Research Institute, PO Box 831, 11016, Kiryat Shmona, Israel.
Hila YehudaMIGAL - Galilee Research Institute, PO Box 831, 11016, Kiryat Shmona, Israel.
Bridget KnightRoyal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital, Barrack Road, Exeter, UK.
Malcolm CrundwellRoyal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital, Barrack Road, Exeter, UK.
Douglas FergusonRoyal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital, Barrack Road, Exeter, UK.
Benjamin P LeeUniversity of Exeter Medical School, Barrack Road, Exeter, UK.
Lorna W HarriesUniversity of Exeter Medical School, Barrack Road, Exeter, UK. L.W.Harries@exeter.ac.uk.ORCID http://orcid.org/0000-0001-7791-8061
University of Exeter · GBMigal - Galilee Technology Center · ILRoyal Devon & Exeter NHS Foundation Trust · GB

Funding

Daniel Turnburg Travel Award N/AD-Cure/MOH-CSO N/AIsrael Cancer Research Fund N/A
6 · The paper itself

Abstract

backgroundObesity increases breast cancer (BC) risk in post-menopausal women by mostly unknown molecular mechanisms which may partly be regulated by microRNAs (miRNAs).

methodsWe isolated RNA from paired benign and malignant biopsies from 83 BC patients and determined miRNA profiles in samples from 12 women at the extremes of the BMI distribution by RNA-seq. Candidates were validated in all samples. Associations between miR-10b expression and validated target transcript levels, and effects of targeted manipulation of miR-10b levels in a primary BC cell line on proliferation and invasion potential, were explored.

resultsOf the 148 miRNAs robustly expressed in breast tissues, the levels of miR-21, miR-10b, miR-451a, miR-30c, and miR-378d were significantly associated with presence of cancer. Of these, miR-10b showed a stronger down-regulation in the tumors of the obese subjects, as opposed to the lean. In ductal but not lobular tumors, significant inverse correlations were observed between the tumor levels of miR-10b and miR-30c and the mRNA levels of cancer-relevant target genes SRSF1, PIEZO1, MAPRE1, CDKN2A, TP-53 and TRA2B, as well as tumor grade. Suppression of miR-10b levels in BT-549 primary BC-derived cells increased cell proliferation and invasive capacity, while exogenous miR-10b mimic decreased invasion. Manipulation of miR-10b levels also inversely affected the mRNA levels of miR-10b targets BCL2L11, PIEZO1 and NCOR2.

conclusionsOur findings suggest that miR-10b may be a mediator between obesity and cancer in post-menopausal women, regulating several known cancer-relevant genes. MiR-10b expression may have diagnostic and therapeutic implications for the incidence and prognosis of BC in obese women.

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedAged, 80 and overBreast NeoplasmsDown-RegulationFemaleGene Expression ProfilingHumansMicroRNAsMiddle AgedObesityPrognosisTumor Cells, CulturedMicroRNAsMIRN10 microRNA, humanBreast cancermicroRNAmiR-10bObesityOncogenesTumor suppressors

Identifiers

PMID30658617
PMCPMC6339293
OpenAlexW2919610063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.